Skip to main content
. 2010 Dec;51(6):524–533. doi: 10.3325/cmj.2010.51.524

Table 5.

Antibiotics used in lower respiratory tract infections (total DDDs) with proportions of their total use (in percentages)*

Antibiotic Total consumption (DDD) Consumption lower respiratory tract infections Influenza Pneumonia Acute bronchitis Chronic bronchitis Asthma
Amoxicillin
210  223
12 897 (6.13)
873 (0.41)
209 (0.09)
10 944 (5.20)
232 (0.11)
584 (0.27)
Co-amoxiclav
194  118
35 273 (18.17)
404 (0.20)
7447 (3.83)
25 830 (13.30)
454 (0.23)
1141 (0.58)
Cephalexin
76  927
10 881 (14.14)
168 (0.21)
457 (0.59)
9827 (12.77)
104 (0.13)
329 (0.42)
Azithromycin
54  726
12 409 (22.67)
95 (0.17)
3311 (6.05)
8368 (15.29)
93 (0.17)
545 (0.99)
Cefuroxime
53  329
14 807 (27.76)
170 (0.31)
2588 (4.85)
11 295 (21.17)
296 (0.55)
460 (0.86)
Doxycyclin
35  217
9936 (28.21)
288 (0.81)
1338 (3.80)
7780 (22.09)
0
530 (1.50)
Ceftibuten
20  866
1317 (6.31)
0
189 (0.90)
978 (4.68)
45 (0.21)
95 (0.45)
Clarithromycin
9661
2355 (24.37)
0
1024 (10.60)
1175 (12.16)
154 (1.56)
0
Co-trimox 89  688 2801 (3.12) 75 (0.08) 245 (0.27) 1612 (1.49) 873 (0.97) 0
Total 102 676 (100) 2073 (2.19) 16 808 (16.36) 77 809 (75.78) 2251 (2.19) 3684 (3.58)

*DDD – defined daily dose.